AAAAAA
Results:
1-7
|
Results: 7
Authors:
Lakehal, F
Dansette, PM
Becquemont, L
Lasnier, E
Delelo, R
Balladur, P
Poupon, R
Beaune, PH
Housset, C
Citation: F. Lakehal et al., Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes, CHEM RES T, 14(6), 2001, pp. 694-701
Authors:
Morin, S
Loriot, MA
Poirier, JM
Tenneze, L
Beaune, PH
Funck-Brentano, C
Jaillon, P
Becquemont, L
Citation: S. Morin et al., Is diclofenac a valuable CYP2C9 probe in humans?, EUR J CL PH, 56(11), 2001, pp. 793-797
Authors:
Beaune, PH
Loriot, MA
Citation: Ph. Beaune et Ma. Loriot, Molecular basis of individual susceptibility to xenobiotics, M S-MED SCI, 16(10), 2000, pp. 1051-1056
Authors:
Thijssen, HH
Flinois, JP
Beaune, PH
Citation: Hh. Thijssen et al., Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes, DRUG META D, 28(11), 2000, pp. 1284-1290
Authors:
Louerat-Oriou, B
Flinois, JP
Beaune, PH
Pompon, D
Citation: B. Louerat-oriou et al., High yield purification and characterization of engineered human P450 1A2 and generation of immuno-inhibitor antibodies, PHARMACOGEN, 9(1), 1999, pp. 61-70
Authors:
Lakehal, F
Wendum, D
Barbu, V
Becquemont, L
Poupon, R
Balladur, P
Hannoun, L
Ballet, F
Beaune, PH
Housset, C
Citation: F. Lakehal et al., Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium, HEPATOLOGY, 30(6), 1999, pp. 1498-1506
Authors:
Dansette, PM
Bonierbale, E
Minoletti, C
Beaune, PH
Pessayre, D
Mansuy, D
Citation: Pm. Dansette et al., Drug-induced immunotoxicity, EUR J DRUG, 23(4), 1998, pp. 443-451
Risultati:
1-7
|